Literature DB >> 10193334

Malignant fibrothecomatous tumour of the ovary: diagnostic value of anti-inhibin immunostaining.

W G McCluggage1, J M Sloan, D D Boyle, P G Toner.   

Abstract

Malignant ovarian tumours of the fibrothecoma group are rare. The clinicopathological features of a case of ovarian malignant fibrothecoma in which there was metastatic disease in the small intestine and peritoneum at presentation are described. A number of differential diagnoses were considered but positive immunohistochemical staining of the resected ovarian and small intestinal neoplasms with anti-inhibin was of value in confirming a sex cord-stromal tumour and in excluding other lesions. The two tumours were also ultrastructurally identical. Classical malignant fibrothecomas are said to show four or more mitotic figures per 10 high power fields (HPF). Although the intestinal secondary was mitotically active, the primary ovarian tumour contained only one to two mitoses per 10 HPF, showing that formal mitotic counts are not an absolute indicator of malignant behaviour in this group of tumours.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193334      PMCID: PMC500987          DOI: 10.1136/jcp.51.11.868

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Fibroma of the ovary with abdominal implants.

Authors:  R O LYDAY
Journal:  Am J Surg       Date:  1952-12       Impact factor: 2.565

2.  Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin.

Authors:  W G McCluggage; P Maxwell; J M Sloan
Journal:  Hum Pathol       Date:  1997-09       Impact factor: 3.466

3.  Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases.

Authors:  J Prat; R E Scully
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

4.  Fibrosarcoma versus cellular fibroma of the ovary: a comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluorescence in situ hybridization.

Authors:  T Tsuji; S Kawauchi; T Utsunomiya; Y Nagata; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  1997-01       Impact factor: 6.394

Review 5.  Ovarian low-grade stromal sarcoma with thecomatous features: a critical reappraisal of the so-called "malignant thecoma".

Authors:  M Waxman; J C Vuletin; R Urcuyo; C G Belling
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

6.  Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma.

Authors:  P Flemming; A Wellmann; H Maschek; H Lang; A Georgii
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

7.  Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung.

Authors:  E J Nouwen; D E Pollet; M W Eerdekens; P G Hendrix; T W Briers; M E De Broe
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

8.  Circulating immunoreactive inhibin levels during the normal human menstrual cycle.

Authors:  R I McLachlan; D M Robertson; D L Healy; H G Burger; D M de Kretser
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

9.  Giant fibrosarcoma of the ovary.

Authors:  P A Miles; K C Kiley; H Mena
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

  9 in total
  7 in total

Review 1.  Mitotically active cellular fibroma of ovary should be differentiated from fibrosarcoma: a case report and review of literature.

Authors:  Lin Zong; Ming Lin; Xinmin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 2.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

3.  Ovarian Fibrosarcoma: Clinicopathologic Considerations about the Intraoperative and Post-Surgical Procedures.

Authors:  Angel García Jiménez; Josep Castellví; Assumpció Pérez Benavente; Isabela Díaz de Corcuera Frutos; Santiago Ramón Y Cajal
Journal:  Case Rep Med       Date:  2010-02-07

4.  Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.

Authors:  Long Huang; Ling-Min Liao; Hui-Yun Wang; Min Zheng
Journal:  BMC Cancer       Date:  2010-10-27       Impact factor: 4.430

5.  Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns - looking for prognostic markers: a case report.

Authors:  Wojciech Jozwicki; Anna Aneta Brożyna; Małgorzata Walentowicz; Marek Grabiec
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

6.  Giant primary ovarian fibrosarcoma: Case report and review of pitfalls.

Authors:  Sumit Ray; Biplab K Biswas; Subhalakshmi Mukhopadhyay
Journal:  J Cytol       Date:  2012-10       Impact factor: 1.000

7.  The co-existence of a myxoid liposarcoma and leiomyoma in the same ovarian mass of a dog.

Authors:  Nozomi Shiwa; Hassadin Boonsriroj; Kazunori Kimitsuki; Taichi Shimatsu; Chun-Ho Park
Journal:  J Vet Med Sci       Date:  2015-10-31       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.